These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10050179)

  • 41. [Tadenan (Pygeum africanum extract) in the treatment of patients with benign prostatic hyperplasia].
    Urologiia; 2004; (5):70-2. PubMed ID: 15560171
    [No Abstract]   [Full Text] [Related]  

  • 42. [Conservative therapy of prostatic hypertrophy with Fink Prosta capsules].
    Lütgen T
    Dtsch Med J; 1970 May; 21(9):625-6. PubMed ID: 4098219
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of prostatic hypertrophy with eviprostat].
    Kubo Y; Inoue S; Ono T; Yasui A
    Hinyokika Kiyo; 1966 Dec; 12(12):1463-7. PubMed ID: 4167083
    [No Abstract]   [Full Text] [Related]  

  • 44. How to beat the post-saw palmetto blues. Despite disappointing scientific tests of saw palmetto to ease bothersome urinary symptoms, men still have self-help options.
    Harv Mens Health Watch; 2012 Jun; 16(11):3. PubMed ID: 22768405
    [No Abstract]   [Full Text] [Related]  

  • 45. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
    Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O
    MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182
    [No Abstract]   [Full Text] [Related]  

  • 46. Managing benign prostate disease.
    Eddy B; Anderson C
    Practitioner; 2002 Dec; 246(1641):812-5, 817-9. PubMed ID: 12489357
    [No Abstract]   [Full Text] [Related]  

  • 47. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.
    Lowe FC; Dreikorn K; Borkowski A; Braeckman J; Denis L; Ferrari P; Gerber G; Levin R; Perrin P; Senge T
    Prostate; 1998 Nov; 37(3):187-93. PubMed ID: 9792136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pygeum.
    McQueen CE; Bryant PJ
    Am J Health Syst Pharm; 2001 Jan; 58(2):120-3. PubMed ID: 11202534
    [No Abstract]   [Full Text] [Related]  

  • 49. [Tumorous prostatic diseases. I. Prostatic adenoma--genesis, clinical aspects, therapy].
    Reichelt H
    Z Allgemeinmed; 1974 May; 50(15):688-93. PubMed ID: 4137484
    [No Abstract]   [Full Text] [Related]  

  • 50. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 51. Herbal prostate remedies?
    Gerber GS
    Health News; 1998 Oct; 4(12):1-2. PubMed ID: 9772829
    [No Abstract]   [Full Text] [Related]  

  • 52. [BPH pharmacotherapy (miscellaneous)].
    Okada H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():367-72. PubMed ID: 12599602
    [No Abstract]   [Full Text] [Related]  

  • 53. [Regression of the symptoms of prostatic adenomas. Results of 6 months' conservative treatment using ERU capsules].
    Maar K
    Fortschr Med; 1987 Jan; 105(1):18-20. PubMed ID: 2435642
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of a preparation with pollen extract base in patients with prostatic hypertrophy].
    Inada T; Kitagawa T; Miyakawa M
    Clin Ter; 1970 Jun; 53(5):431-8. PubMed ID: 4097408
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study.
    Avins AL; Bent S; Neuhaus JM
    Contemp Clin Trials; 2005 Jun; 26(3):397-401. PubMed ID: 15911473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trial of gestronol hexanoate (SH582) in benign prostatic hypertrophy.
    Gengell JC; Miller IM; Roberts JB
    Proc R Soc Med; 1972 Feb; 65(2):130. PubMed ID: 4117437
    [No Abstract]   [Full Text] [Related]  

  • 57. [Double-blind test on the therapeutic effects of a prostatic extract in the clinical syndrome of prostatic adenoma].
    Arduini M; Trucchi E
    Minerva Urol; 1972; 24(5):167-72. PubMed ID: 4141050
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prostatic syndrome. Long term therapy with Prostamed].
    Djulepa J
    ZFA (Stuttgart); 1980 Apr; 56(11):813-6. PubMed ID: 6159745
    [No Abstract]   [Full Text] [Related]  

  • 59. [Action of the combination of hypothalamic phospholipids and megestrol acetate (IP 11) in prostatic hypertrophy. Results of a controlled clinical trial].
    Mazza G; Petracco S
    Minerva Urol; 1974; 26(6):293-300. PubMed ID: 4142804
    [No Abstract]   [Full Text] [Related]  

  • 60. [Phytopharmaceutic drugs in treatment of sleep disorders].
    Nachtmann A; Hajak G
    Internist (Berl); 1996 Jul; 37(7):743-9. PubMed ID: 8766272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.